AAPL$175.12+0.45%GOOGL$2,835.67-0.22%BTC-USD$64,250.33+1.10%ETH-USD$3,200.42-0.75%TSLA$720.15+2.01%MSFT$312.55-0.13%AMZN$3,420.74+0.38%META$270.61-0.55%NFLX$410.22+1.25%NVDA$890.12+2.70%GOLD$2,345.15+0.21%SILVER$28.44-0.32%OIL$84.12+1.10%NATGAS$2.65-0.18%CORN$6.32+0.07%WHEAT$6.95-0.09%COFFEE$2.15+0.80%SUGAR$0.25+0.05%PORKBELLIES$1.12+0.12%

Money News

Stay tuned for updates and news from Interconnection.

Billionaires like Ken Griffin are doling out tons of money to prove that a college degree still mattersSynopsys, OpenAI strike deal to develop AI model for chip design work Jefferies Highlights Three Biotech Stocks With Blockbuster PotentialUS wants to speed certification of new airplanesMy friend’s pet-sitting business grosses $300,000 a year, but she pays herself $50,000. Should I start one too?SNDK, MRNA, TWST: top large-cap momentum stocksWhy is Liquidia stock cratering today?Crude oil exports through the Strait of Hormuz hit prewar levels, but fuel shipments remain constrainedTwo trades that just happened in 'Magnificent Seven' stocks point to big gains aheadAdding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effectsAfter I sold TOMS Shoes for $400 million I was misdiagnosed with bipolar disorder — and it almost cost me everythingThis chart shows that buying and holding stocks beats ‘sell in May and go away’ and other gimmicksBillionaires like Ken Griffin are doling out tons of money to prove that a college degree still mattersSynopsys, OpenAI strike deal to develop AI model for chip design work Jefferies Highlights Three Biotech Stocks With Blockbuster PotentialUS wants to speed certification of new airplanesMy friend’s pet-sitting business grosses $300,000 a year, but she pays herself $50,000. Should I start one too?SNDK, MRNA, TWST: top large-cap momentum stocksWhy is Liquidia stock cratering today?Crude oil exports through the Strait of Hormuz hit prewar levels, but fuel shipments remain constrainedTwo trades that just happened in 'Magnificent Seven' stocks point to big gains aheadAdding Lilly’s new drug to Zepbound helped people lose more weight — but there were more side effectsAfter I sold TOMS Shoes for $400 million I was misdiagnosed with bipolar disorder — and it almost cost me everythingThis chart shows that buying and holding stocks beats ‘sell in May and go away’ and other gimmicks

Financial News (CNBC, Investing.com, MarketWatch)

Click the news headlines below to view the full stories.

MarketWatch.com - Top Stories: 5 itemsStock Market News: 5 itemsUS Top News and Analysis: 2 items